| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/3/267:00 AM | -$0.73 | -$0.61GAAP | +16.4% | +26% | $84.6M | $92.1M | +8.9% | +80% | |
| Q2 '26 | 8/4/267:00 AM | -$0.84 | -$0.73GAAP | +13.1% | +3% | $67.2M | $71.3M | +6.0% | +47% | |
| Q1 '26 | 5/5/267:00 AM | -$0.86 | -$0.83GAAP | +3.5% | -2% | $56.2M | $60.1M | +7.0% | +84% | |
| Q4 '25 | 2/26/267:00 AM | -$0.78 | -$0.73GAAP | +6.4% | -1% | $55.8M | $57.3M | +2.5% | +37% | |
| Q3 '25 | 11/4/257:00 AM | -$0.72 | -$0.82GAAP | -13.9% | -12% | $50.5M | $51.3M | +1.6% | +54% | |
| Q2 '25 | 8/5/257:00 AM | -$0.67 | -$0.75GAAP | -11.9% | -36% | $43.5M | $48.5M | +11.4% | +67% | |
| Q1 '25 | 5/7/257:00 AM | -$0.68 | -$0.81GAAP | -19.1% | +66% | $40.7M | $32.7M | -19.6% | +26% |
GAAP = diluted EPS as filed with the SEC.